Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation

Journal of Leukocyte Biology

Volumn 90, Issue 1, 2011, Pages 49-60

  Merindol, Natacha ^a,c,d   Charrier, Emily ^a,b,c,d   Duval, Michel ^a,b,c,d   Soudeyns, Hugo ^a,c,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Laboratoire d'immunologie du sang de cordon   (Canada)

^c Centre de Cancerologie Charles Bruneau   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cytokines; MHC; Molecules; Primary cell

Indexed keywords

CD161 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 7; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; METHOTREXATE; METHYLPREDNISOLONE; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHIMERA; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; EPSTEIN BARR VIRUS INFECTION; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC CELL; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INFLAMMATION; LEUKEMIA RELAPSE; LEUKOCYTE; LYMPHOCYTE COUNT; LYMPHOID PROGENITOR CELL; MORBIDITY; MORTALITY; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; NONHUMAN; OPPORTUNISTIC INFECTION; OVERALL SURVIVAL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T CELL DEPLETION; T LYMPHOCYTE; THYMUS; TREATMENT OUTCOME;

CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 79959813984     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0111007     Document Type: Review

References (154)

1. Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., Friedman, H. S., Douglas, G. W., Devergie, A., Esperou, H., Thierry, D., Socie, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J., Boyse, E. A. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178.
2. Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A. R., Berkowitz, R. L., Cabbad, M., Dobrila, N. L., Taylor, P. E., Rosenfield, R. E., Stevens, C. E. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339, 1565-1577.
3. Barker, J. N., Wagner, J. E. (2003) Umbilical-cord blood transplantation for the treatment of cancer. Nat. Rev. Cancer 3, 526-532.
4. National Marrow Donor Program (2010) www.marrow.org/PHYSICIAN/URD_Search_and_Tx/Number_of_Allogeneic_Tx_Perfor/Index.html#grafts
5. Wagner, J. E., Rosenthal, J., Sweetman, R., Shu, X. O., Davies, S. M., Ramsay, N. K., McGlave, P. B., Sender, L., Cairo, M. S. (1996) Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graftversus-host disease. Blood 88, 795-802.
6. Rocha, V., Cornish, J., Sievers, E. L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K. W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A. L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S., Gluckman, E. (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97, 2962-2971.
7. Hwang, W. Y., Samuel, M., Tan, D., Koh, L. P., Lim, W., Linn, Y. C. (2007) A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol. Blood Marrow Transplant. 13, 444-453.
8. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J. P., Fernandez, M., Chastang, C. (1997) Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337, 373-381.
9. Rubinstein, P., Rosenfield, R. E., Adamson, J. W., Stevens, C. E. (1993) Stored placental blood for unrelated bone marrow reconstitution. Blood 81, 1679-1690.
10. Wagner, E., Duval, M., Dalle, J. H., Morin, H., Bizier, S., Champagne, J., Champagne, M. A. (2006) Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 46, 1190-1198.
11. Thomson, B. G., Robertson, K. A., Gowan, D., Heilman, D., Broxmeyer, H. E., Emanuel, D., Kotylo, P., Brahmi, Z., Smith, F. O. (2000) Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 96, 2703-2711.
12. Dalle, J. H., Duval, M., Moghrabi, A., Wagner, E., Vachon, M. F., Barrette, S., Bernstein, M., Champagne, J., David, M., Demers, J., Rousseau, P., Winikoff, R., Champagne, M. A. (2004) Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant. 33, 605-611.
13. Rocha, V., Gluckman, E. (2006) Clinical use of umbilical cord blood hematopoietic stem cells. Biol. Blood Marrow Transplant. 12, 34-41.
14. Barker, J. N., Hough, R. E., van Burik, J. A., DeFor, T. E., MacMillan, M. L., O'Brien, M. R., Wagner, J. E. (2005) Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol. Blood Marrow Transplant. 11, 362-370.
15. Eapen, M., Rubinstein, P., Zhang, M. J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F. R., Champlin, R. E., Klein, J. P., Horowitz, M. M., Wagner, J. E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 369, 1947-1954.
16. Kurtzberg, J., Prasad, V. K., Carter, S. L., Wagner, J. E., Baxter-Lowe, L. A., Wall, D., Kapoor, N., Guinan, E. C., Feig, S. A., Wagner, E. L., Kernan, N. A. (2008) Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112, 4318-4327.
17. Pavletic, Z. S., Joshi, S. S., Pirruccello, S. J., Tarantolo, S. R., Kollath, J., Reed, E. C., Bierman, P. J., Vose, J. M., Warkentin, P. I., Gross, T. G., Nasrati, K., Armitage, J. O., Kessinger, A., Bishop, M. R. (1998) Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 21, 33-41.
18. Le Blanc, K., Barrett, A. J., Schaffer, M., Hagglund, H., Ljungman, P., Ringden, O., Remberger, M. (2009) Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol. Blood Marrow Transplant. 15, 1108-1115.
19. Kumar, S., Chen, M. G., Gastineau, D. A., Gertz, M. A., Inwards, D. J., Lacy, M. Q., Tefferi, A., Litzow, M. R. (2003) Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia 17, 1865-1870.
20. Ishaqi, M. K., Afzal, S., Dupuis, A., Doyle, J., Gassas, A. (2008) Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant. 41, 245-252.
21. Kim, D. H., Kim, J. G., Sohn, S. K., Sung, W. J., Suh, J. S., Lee, K. S., Lee, K. B. (2004) Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br. J. Haematol. 125, 217-224.
22. Locatelli, F., Maccario, R., Comoli, P., Bertolini, F., Giorgiani, G., Montagna, D., Bonetti, F., De, S. P., Rondini, G., Sirchia, G., Severi, F. (1996) Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplant. 18, 1095-1101.
23. Niehues, T., Rocha, V., Filipovich, A. H., Chan, K. W., Porcher, R., Michel, G., Ortega, J. J., Wernet, P., Gobel, U., Gluckman, E., Locatelli, F. (2001) Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children-a Eurocord analysis. Br. J. Haematol. 114, 42-48.
24. Moretta, A., Maccario, R., Fagioli, F., Giraldi, E., Busca, A., Montagna, D., Miniero, R., Comoli, P., Giorgiani, G., Zecca, M., Pagani, S., Locatelli, F. (2001) Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp. Hematol. 29, 371-379.
25. Barlogis, V., Glasman, L., Brunet, C., Loundou, A. D., Lemarie, C., Galambrun, C., Thuret, I., Curtillet, C., Le, M. M., Bernard, F., Chambost, H., Calmels, B., Picard, C., Chabannon, C., Dignat-George, F., Michel, G. (2011) Impact of viable CD45 cells infused on lymphocyte subset recovery after unrelated cord blood transplantation in children. Biol. Blood Marrow Transplant. 17, 109-116.
26. Velardi, A., Ruggeri, L., Mancusi, A., Aversa, F., Christiansen, F. T. (2009) Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia. Curr. Opin. Immunol. 21, 525-530.
27. Parham, P., McQueen, K. L. (2003) Alloreactive killer cells: hindrance and help for hematopoietic transplants. Nat. Rev. Immunol. 3, 108-122.
28. Lopez-Vergés, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J., Nixon, D. F., Lanier, L. L. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116, 3865-3874.
29. Le Garff-Tavernier, M., Béziat, V., Decocq, J., Siguret, V., Gandjbakhch, F., Pautas, E., Debré, P., Merle-Beral, H., Vieillard, V. (2010) Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9, 527-535.
30. Beziat, V., Nguyen, S., Lapusan, S., Hervier, B., Dhedin, N., Bories, D., Uzunov, M., Boudifa, A., Trebeden-Negre, H., Norol, F., Marjanovic, Z., Marie, J. P., Vernant, J. P., Debre, P., Rio, B., Vieillard, V. (2009) Fully functional NK cells after unrelated cord blood transplantation. Leukemia 23, 721-728.
31. Björkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Björklund, A. T., Flodström-Tullberg, M., Michaëlsson, J., Rottenberg, M. E., Guzmán, C. A., Ljunggren, H. G., Malmberg, K. J. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116, 3853-3864.
32. Vago, L., Forno, B., Sormani, M. P., Crocchiolo, R., Zino, E., Di, T. S., Lupo Stanghellini, M. T., Mazzi, B., Perna, S. K., Bondanza, A., Middleton, D., Palini, A., Bernardi, M., Bacchetta, R., Peccatori, J., Rossini, S., Roncarolo, M. G., Bordignon, C., Bonini, C., Ciceri, F., Fleischhauer, K. (2008) Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood 112, 3488-3499.
33. Nguyen, S., Dhedin, N., Vernant, J. P., Kuentz, M., Al, J. A., Rouas-Freiss, N., Carosella, E. D., Boudifa, A., Debre, P., Vieillard, V. (2005) NKcell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105, 4135-4142.
34. Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., Conte, R., Strowig, T., Moretta, A., Münz, C., Thiel, A., Moretta, L., Ferlazzo, G. (2007) CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178, 4947-4955.
35. Brahmi, Z., Hommel-Berrey, G., Smith, F., Thomson, B. (2001) NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum. Immunol. 62, 782-790.
36. Garderet, L., Dulphy, N., Douay, C., Chalumeau, N., Schaeffer, V., Zilber, M. T., Lim, A., Even, J., Mooney, N., Gelin, C., Gluckman, E., Charron, D., Toubert, A. (1998) The umbilical cord blood αβ T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 91, 340-346.
37. Merindol, N., Grenier, A. J., Caty, M., Charrier, E., Duval, A., Duval, M., Champagne, M. A., Soudeyns, H. (2010) Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells. J. Immunol. 185, 856-866.
38. Mackall, C. L., Bare, C. V., Granger, L. A., Sharrow, S. O., Titus, J. A., Gress, R. E. (1996) Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156, 4609-4616.
39. Klein, A. K., Patel, D. D., Gooding, M. E., Sempowski, G. D., Chen, B. J., Liu, C., Kurtzberg, J., Haynes, B. F., Chao, N. J. (2001) T-cell recovery in adults and children following umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 7, 454-466.
40. Komanduri, K. V., St John, L. S., de Lima, M., McMannis, J., Rosinski, S., McNiece, I., Bryan, S. G., Kaur, I., Martin, S., Wieder, E. D., Worth, L., Cooper, L. J., Petropoulos, D., Molldrem, J. J., Champlin, R. E., Shpall, E. J. (2007) Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 110, 4543-4551.
41. Gorla, R., Airo, P., Ferremi-Leali, P., Rossi, G., Prati, E., Brugnoni, D., Cattaneo, R. (1993) Predominance of "memory" phenotype within CD4+ and CD8+ lymphocyte subsets after allogeneic BMT. Bone Marrow Transplant. 11, 346-347.
42. Eyrich, M., Leiler, C., Lang, P., Schilbach, K., Schumm, M., Bader, P., Greil, J., Klingebiel, T., Handgretinger, R., Niethammer, D., Schlegel, P. G. (2003) A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant. 32, 379-390.
43. Talvensaari, K., Clave, E., Douay, C., Rabian, C., Garderet, L., Busson, M., Garnier, F., Douek, D., Gluckman, E., Charron, D., Toubert, A. (2002) A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99, 1458-1464.
44. Robin, C., Bennaceur-Griscelli, A., Louache, F., Vainchenker, W., Coulombel, L. (1999) Identification of human T-lymphoid progenitor cells in CD34+ CD38low and CD34+ CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Br. J. Haematol. 104, 809-819.
45. Goronzy, J. J., Weyand, C. M. (2005) T cell development and receptor diversity during aging. Curr. Opin. Immunol. 17, 468-475.
46. Finocchi, A., Romiti, M. L., Di Cesare, S., Puliafito, P., Pensieroso, S., Rana, I., Pinto, R., Cancrini, C., De Rossi, G., Caniglia, M., Rossi, P. (2006) Rapid T-cell receptor CD4+ repertoire reconstitution and immune recovery in unrelated umbilical cord blood transplanted pediatric leukemia patients. J. Pediatr. Hematol. Oncol. 28, 403-411.
47. Canque, B., Camus, S., Dalloul, A., Kahn, E., Yagello, M., Dezutter-Dambuyant, C., Schmitt, D., Schmitt, C., Gluckman, J. C. (2000) Characterization of dendritic cell differentiation pathways from cord blood CD34+CD7+CD45RA+ hematopoietic progenitor cells. Blood 96, 3748-3756.
48. Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K., Eguchi, H., Onitsuka, I., Matsui, K., Imaizumi, T. (2000) Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105, 1527-1536.
49. Crisa, L., Cirulli, V., Smith, K. A., Ellisman, M. H., Torbett, B. E., Salomon, D. R. (1999) Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94, 3928-3940.
50. Duval, M., Pedron, B., Rohrlich, P., Legrand, F., Faye, A., Lescoeur, B., Bensaid, P., Larchee, R., Sterkers, G., Vilmer, E. (2002) Immune reconstitution after hematopoietic transplantation with two different doses of pre-graft antithymocyte globulin. Bone Marrow Transplant. 30, 421-426.
51. Ballen, K. K., Spitzer, T. R., Yeap, B. Y., McAfee, S., Dey, B. R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, V., Antin, J. H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant. 13, 82-89.
52. Brunstein, C. G., Barker, J. N., Weisdorf, D. J., DeFor, T. E., Miller, J. S., Blazar, B. R., McGlave, P. B., Wagner, J. E. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110, 3064-3070.
53. Barker, J. N., Weisdorf, D. J., DeFor, T. E., Blazar, B. R., McGlave, P. B., Miller, J. S., Verfaillie, C. M., Wagner, J. E. (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105, 1343-1347.
54. Kang, H. J., Yoo, K. H., Lee, J. W., Kim, H., Lee, S. H., Sung, K. W., Park, K. D., Koo, H. H., Shin, H. Y., Ahn, H. S. (2010) Double umbilical cord blood transplantation for children and adolescents. Ann. Hematol. 89, 1035-1044.
55. Verneris, M. R., Brunstein, C. G., Barker, J., MacMillan, M. L., DeFor, T., McKenna, D. H., Burke, M. J., Blazar, B. R., Miller, J. S., McGlave, P. B., Weisdorf, D. J., Wagner, J. E. (2009) Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 114, 4293-4299.
56. Voogt, P. J., Fibbe, W. E., Marijt, W. A., Goulmy, E., Veenhof, W. F., Hamilton, M., Brand, A., Zwann, F. E., Willemze, R., van Rood, J. J. (1990) Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335, 131-134.
57. Marijt, W. A., Kernan, N. A., Diaz-Barrientos, T., Veenhof, W. F., O'Reilly, R. J., Willemze, R., Falkenburg, J. H. (1995) Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant. 16, 125-132.
58. Mattsson, J., Ringdén, O., Storb, R. (2008) Graft failure after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 14 (Suppl.1), 165-170.
59. Murphy, W. J., Keller, J. R., Harrison, C. L., Young, H. A., Longo, D. L. (1992) Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo. Blood 80, 670-677.
60. Hirayama, M., Genyea, C., Brownell, A., Kaplan, J. (1998) IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients. Bone Marrow Transplant. 21, 1245-1252.
61. Siefer, A. K., Longo, D. L., Harrison, C. L., Reynolds, C. W., Murphy, W. J. (1993) Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice. Blood 82, 2577-2584.
62. Lanier, L. L. (1998) NK cell receptors. Annu. Rev. Immunol. 16, 359-393.
63. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M. F., Velardi, A. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100.
64. Willemze, R., Rodrigues, C. A., Labopin, M., Sanz, G., Michel, G., Socie, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mohty, M., Ferra, C., Garnier, F., Loiseau, P., Garcia, J., Lecchi, L., Kogler, G., Beguin, Y., Navarrete, C., Devos, T., Ionescu, I., Boudjedir, K., Herr, A. L., Gluckman, E., Rocha, V. (2009) KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 23, 492-500.
65. Brunstein, C. G., Wagner, J. E., Weisdorf, D. J., Cooley, S., Noreen, H., Barker, J. N., DeFor, T., Verneris, M. R., Blazar, B. R., Miller, J. S. (2009) Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood 113, 5628-5634.
66. Dalle, J. H., Menezes, J., Wagner, E., Blagdon, M., Champagne, J., Champagne, M. A., Duval, M. (2005) Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr. Res. 57, 649-655.
67. Dalle, J. H., Dardari, R., Menezes, J., Cordeiro, P., Champagne, M. A., Duval, M. (2009) Binding of thymoglobulin to natural killer cells leads to cell activation and interferon-γ production. Transplantation 87, 473-481.
68. Lau, A. S., Sigaroudinia, M., Yeung, M. C., Kohl, S. (1996) Interleukin-12 induces interferon-γ expression and natural killer cytotoxicity in cord blood mononuclear cells. Pediatr. Res. 39, 150-155.
69. Umemoto, M., Azuma, E., Hirayama, M., Nagai, M., Hiratake, S., Qi, J., Kumamoto, T., Komada, Y., Sakurai, M. (1997) Two cytotoxic pathways of natural killer cells in human cord blood: implications in cord blood transplantation. Br. J. Haematol. 98, 1037-1040.
70. Tanaka, H., Kai, S., Yamaguchi, M., Misawa, M., Fujimori, Y., Yamamoto, M., Hara, H. (2003) Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur. J. Haematol. 71, 29-38.
71. Xing, D., Ramsay, A. G., Gribben, J. G., Decker, W. K., Burks, J. K., Munsell, M., Li, S., Robinson, S. N., Yang, H., Steiner, D., Shah, N., Mc-Mannis, J. D., Champlin, R. E., Hosing, C., Zweidler-McKay, P. A., Shpall, E. J., Bollard, C. M. (2010) Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 ex vivo expansion. J. Immunother. 33, 684-696.
72. Van Heeckeren, W. J., Fanning, L. R., Meyerson, H. J., Fu, P., Lazarus, H. M., Cooper, B. W., Tse, W. W., Kindwall-Keller, T. L., Jaroscak, J., Finney, M. R., Fox, R. M., Solchaga, L., Forster, M., Creger, R. J., Laughlin, M. J. (2007) Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. Br. J. Haematol. 139, 464-474.
73. Terakura, S., Azuma, E., Murata, M., Kumamoto, T., Hirayama, M., Atsuta, Y., Kodera, Y., Yazaki, M., Naoe, T., Kato, K. (2007) Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol. Blood Marrow Transplant. 13, 822-830.
74. Jiang, Z., Adams, G. B., Hanash, A. M., Scadden, D. T., Levy, R. B. (2002) The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 8, 588-596.
75. Hexner, E. O., Danet-Desnoyers, G. A., Zhang, Y., Frank, D. M., Riley, J. L., Levine, B. L., Porter, D. L., June, C. H., Emerson, S. G. (2007) Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation. Biol. Blood Marrow Transplant. 13, 1135-1144.
76. Martin, P. J. (1990) The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant. 6, 283-289.
77. Charak, B. S., Brown, E. G., Mazumder, A. (1995) Augmentation of murine hematopoiesis by interleukin 2-activated irradiated T cells. Transplantation 60, 589-594.
78. Carrington, M., O'Brien, S. J. (2003) The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535-551.
79. Van Rood, J. J., Stevens, C. E., Smits, J., Carrier, C., Carpenter, C., Scaradavou, A. (2009) Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc. Natl. Acad. Sci. USA 106, 19952-19957.
80. Muller, A. M., Linderman, J. A., Florek, M., Miklos, D., Shizuru, J. A. (2010) Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proc. Natl. Acad. Sci. USA 107, 14721-14726.
81. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J. A., Boeckh, M. J. (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol. Blood Marrow Transplant. 15, 1143-1238.
82. Hamza, N. S., Lisgaris, M., Yadavalli, G., Nadeau, L., Fox, R., Fu, P., Lazarus, H. M., Koc, O. N., Salata, R. A., Laughlin, M. J. (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br. J. Haematol. 124, 488-498.
83. Beck, J. C., Wagner, J. E., DeFor, T. E., Brunstein, C. G., Schleiss, M. R., Young, J. A., Weisdorf, D. H., Cooley, S., Miller, J. S., Verneris, M. R. (2010) Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 16, 215-222.
84. Benjamin Jr., D. K., Miller, W. C., Bayliff, S., Martel, L., Alexander, K. A., Martin, P. L. (2002) Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr. Infect. Dis. J. 21, 227-234.
85. Tomonari, A., Iseki, T., Takahashi, S., Ooi, J., Takasugi, K., Shimohakamada, Y., Ohno, N., Nagamura, F., Uchimaru, K., Tani, K., Tojo, A., Asano, S. (2003) Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br. J. Haematol. 122, 802-805.
86. Vandenbosch, K., Ovetchkine, P., Champagne, M. A., Haddad, E., Alexandrov, L., Duval, M. (2008) Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol. Blood Marrow Transplant. 14, 867-871.
87. Burke, M. J., Vogel, R. I., Janardan, S. K., Brunstein, C., Smith, A. R., Miller, J. S., Weisdorf, D., Wagner, J. E., Verneris, M. R. (2010) Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies. Biol. Blood Marrow Transplant., Epub ahead of print.
88. Larghero, J., Rocha, V., Porcher, R., Filion, A., Ternaux, B., Lacassagne, M. N., Robin, M., Peffault de Latour, R., Devergie, A., Biscay, N., Ribaud, P., Benbunan, M., Gluckman, E., Marolleau, J. P., Socie, G. (2007) Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants. Br. J. Haematol. 138, 101-109.
89. Kim, D. H., Sohn, S. K., Lee, N. Y., Baek, J. H., Kim, J. G., Won, D. I., Suh, J. S., Lee, K. B., Shin, I. H. (2005) Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Eur. J. Haematol. 75, 299-308.
90. Cohen, G., Carter, S. L., Weinberg, K. I., Masinsin, B., Guinan, E., Kurtzberg, J., Wagner, J. E., Kernan, N. A., Parkman, R. (2006) Antigenspecific T-lymphocyte function after cord blood transplantation. Biol. Blood Marrow Transplant. 12, 1335-1342.
91. Lin, S. J., Peacock, C. D., Bahl, K., Welsh, R. M. (2007) Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation. J. Exp. Med. 204, 2321-2333.
92. Gallez-Hawkins, G. M., Thao, L., Palmer, J., Dagis, A., Li, X., Franck, A. E., Tegtmeier, B., Lacey, S. F., Diamond, D. J., Forman, S. J., Zaia, J. A. (2009) Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 15, 872-880.
93. Soong, W., Schultz, J. C., Patera, A. C., Sommer, M. H., Cohen, J. I. (2000) Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J. Virol. 74, 1864-1870.
94. Arvin, A. M. (2000) Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 6, 219-230.
95. Schaap, A., Fortin, J. F., Sommer, M., Zerboni, L., Stamatis, S., Ku, C. C., Nolan, G. P., Arvin, A. M. (2005) T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J. Virol. 79, 12921-12933.
96. Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L., Arvin, A. M. (2005) Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. USA 102, 6490-6495.
97. Ku, C. C., Zerboni, L., Ito, H., Graham, B. S., Wallace, M., Arvin, A. M. (2004) Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α. J. Exp. Med. 200, 917-925.
98. Abendroth, A., Morrow, G., Cunningham, A. L., Slobedman, B. (2001) Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J. Virol. 75, 6183-6192.
99. Perruccio, K., Tosti, A., Burchielli, E., Topini, F., Ruggeri, L., Carotti, A., Capanni, M., Urbani, E., Mancusi, A., Aversa, F., Martelli, M. F., Romani, L., Velardi, A. (2005) Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 106, 4397-4406.
100. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F. R., Beck, R., Schumm, M., Lotfi, R., Jahn, G., Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 134, 64-76.
101. Micklethwaite, K. P., Savoldo, B., Hanley, P. J., Leen, A. M., Demmler-Harrison, G. J., Cooper, L. J., Liu, H., Gee, A. P., Shpall, E. J., Rooney, C. M., Heslop, H. E., Brenner, M. K., Bollard, C. M., Dotti, G. (2010) Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood 115, 2695-2703.
102. Hanley, P. J., Cruz, C. R., Savoldo, B., Leen, A. M., Stanojevic, M., Khalil, M., Decker, W., Molldrem, J. J., Liu, H., Gee, A. P., Rooney, C. M., Heslop, H. E., Dotti, G., Brenner, M. K., Shpall, E. J., Bollard, C. M. (2009) Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood 114, 1958-1967.
103. Leen, A. M., Christin, A., Myers, G. D., Liu, H., Cruz, C. R., Hanley, P. J., Kennedy-Nasser, A. A., Leung, K. S., Gee, A. P., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Bollard, C. M. (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 114, 4283-4292.
104. Okas, M., Gertow, J., Uzunel, M., Karlsson, H., Westgren, M., Karre, K., Ringden, O., Mattsson, J., Uhlin, M. (2010) Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantation. J. Immunother. 33, 96-105.
105. Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J., Emerson, S. G. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415.
106. Ferrara, J. L., Cooke, K. R., Pan, L., Krenger, W. (1996) The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14, 473-489.
107. Krenger, W., Ferrara, J. L. (1996) Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15, 50-73.
108. Haczku, A., Alexander, A., Brown, P., Assoufi, B., Li, B., Kay, A. B., Corrigan, C. (1994) The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93, 510-519.
109. Gratama, J. W., Würsch, A. M., Nissen, C., Gratwohl, A., D'Amaro, J., de Gast, G. C., van Rood, J. J., Speck, B. (1986) Influence of graft-versushost disease prophylaxis on early T-lymphocyte regeneration following allogeneic bone marrow transplantation. Br. J. Haematol. 62, 355-365.
110. Rocha, V., Wagner Jr., J. E., Sobocinski, K. A., Klein, J. P., Zhang, M. J., Horowitz, M. M., Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342, 1846-1854.
111. MacMillan, M. L., Weisdorf, D. J., Brunstein, C. G., Cao, Q., DeFor, T. E., Verneris, M. R., Blazar, B. R., Wagner, J. E. (2009) Acute graftversus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 113, 2410-2415.
112. Berthou, C., Legros-Maida, S., Soulie, A., Wargnier, A., Guillet, J., Rabian, C., Gluckman, E., Sasportes, M. (1995) Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 85, 1540-1546.
113. Cantó, E., Rodriguez-Sanchez, J. L., Vidal, S. (2003) Distinctive response of nai{dotless}̈ve lymphocytes from cord blood to primary activation via TCR. J. Leukoc. Biol. 74, 998-1007.
114. Ribeiro-do-Couto, L. M., Boeije, L. C., Kroon, J. S., Hooibrink, B., Breur-Vriesendorp, B. S., Aarden, L. A., Boog, C. J. (2001) High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur. J. Immunol. 31, 3394-3402.
115. Godfrey, W. R., Spoden, D. J., Ge, Y. G., Baker, S. R., Liu, B., Levine, B. L., June, C. H., Blazar, B. R., Porter, S. B. (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105, 750-758.
116. Cupedo, T., Nagasawa, M., Weijer, K., Blom, B., Spits, H. (2005) Development and activation of regulatory T cells in the human fetus. Eur. J. Immunol. 35, 383-390.
117. Mold, J. E., Michaelsson, J., Burt, T. D., Muench, M. O., Beckerman, K. P., Busch, M. P., Lee, T. H., Nixon, D. F., McCune, J. M. (2008) Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 1562-1565.
118. Asai, O., Longo, D. L., Tian, Z. G., Hornung, R. L., Taub, D. D., Ruscetti, F. W., Murphy, W. J. (1998) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 101, 1835-1842.
119. Olson, J. A., Leveson-Gower, D. B., Gill, S., Baker, J., Beilhack, A., Negrin, R. S. (2010) NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood 115, 4293-4301.
120. Yabe, T., Matsuo, K., Hirayasu, K., Kashiwase, K., Kawamura-Ishii, S., Tanaka, H., Ogawa, A., Takanashi, M., Satake, M., Nakajima, K., Tokunaga, K., Inoko, H., Saji, H., Ogawa, S., Juji, T., Sasazuki, T., Kodera, Y., Morishima, Y. (2008) Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol. Blood Marrow Transplant. 14, 75-87.
121. Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K. W., Filipovich, A., Takahashi, T. A., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P. J., Yaniv, I., Machado, A., Pimentel, P., Fagioli, F., Verdeguer, A., Jouet, J. P., Diez, B., Ferreira, E., Pasquini, R., Rosenthal, J., Sievers, E., Messina, C., Iori, A. P., Garnier, F., Ionescu, I., Locatelli, F., Gluckman, E. (2003) Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102, 4290-4297.
122. Parkman, R., Cohen, G., Carter, S. L., Weinberg, K. I., Masinsin, B., Guinan, E., Kurtzberg, J., Wagner, J. E., Kernan, N. A. (2006) Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol. Blood Marrow Transplant. 12, 919-927.
123. Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157, 125-140.
124. Falkenburg, J. H., Marijt, W. A., Heemskerk, M. H., Willemze, R. (2002) Minor histocompatibility antigens as targets of graft-versus-leukemia reactions. Curr. Opin. Hematol. 9, 497-502.
125. Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., Hoelzer, D. (1997) High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90, 1217-1225.
126. Menssen, H. D., Renkl, H. J., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., Reinhardt, R., Thiel, E. (1995) Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9, 1060-1067.
127. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K. (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84, 3071-3079.
128. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T., Sugiyama, H. (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89, 1405-1412.
129. Mommaas, B., Stegehuis-Kamp, J. A., van Halteren, A. G., Kester, M., Enczmann, J., Wernet, P., Kogler, G., Mutis, T., Brand, A., Goulmy, E. (2005) Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105, 1823-1827.
130. Keil, F., Prinz, E., Moser, K., Mannhalter, C., Kalhs, P., Worel, N., Rabitsch, W., Schulenburg, A., Mitterbauer, M., Greinix, H. (2003) Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation 76, 230-236.
131. Huisman, C., de Weger, R. A., de Vries, L., Tilanus, M. G., Verdonck, L. F. (2007) Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia. Bone Marrow Transplant. 39, 285-291.
132. Joshi, S. S., Babushkina-Patz, N. N., Verbik, D. J., Gross, T. G., Tarantolo, S. R., Kuszynski, C. A., Pirruccello, S. J., Bishop, M. R., Kessinger, A. (1998) Antitumor activity of human umbilical cord blood cells: a comparative analysis with peripheral blood and bone marrow cells. Int. J. Oncol. 13, 791-799.
133. Joshi, S. S., Tarantolo, S. R., Kuszynski, C. A., Kessinger, A. (2000) Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer. Clin. Cancer Res. 6, 4351-4358.
134. Clark, E. M., Joshi, D. S., Grimm, A. B., Joshi, A. D., Wang, P., Joshi, S. S. (2010) Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: a comparative analysis with peripheral blood and bone marrow. Int. J. Oncol. 37, 645-653.
135. Mazur, M. A., Davis, C. C., Szabolcs, P. (2008) Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation. Biol. Blood Marrow Transplant. 14, 1190-1196.
136. Davis, C. C., Marti, L. C., Sempowski, G. D., Jeyaraj, D. A., Szabolcs, P. (2010) Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation. Cancer Res. 70, 5249-5258.
137. Ruggeri, L., Mancusi, A., Burchielli, E., Capanni, M., Carotti, A., Aloisi, T., Aversa, F., Martelli, M. F., Velardi, A. (2008) NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol. Dis. 40, 84-90.
138. Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., Velardi, A. (1999) Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94, 333-339.
139. Romanski, A., Bug, G., Becker, S., Kampfmann, M., Seifried, E., Hoelzer, D., Ottmann, O. G., Tonn, T. (2005) Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia. Exp. Hematol. 33, 344-352.
140. Kato, N., Tanaka, J., Sugita, J., Toubai, T., Miura, Y., Ibata, M., Syono, Y., Ota, S., Kondo, T., Asaka, M., Imamura, M. (2007) Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21, 2103-2108.
141. Imai, C., Iwamoto, S., Campana, D. (2005) Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood 106, 376-383.
142. Giebel, S., Locatelli, F., Lamparelli, T., Velardi, A., Davies, S., Frumento, G., Maccario, R., Bonetti, F., Wojnar, J., Martinetti, M., Frassoni, F., Giorgiani, G., Bacigalupo, A., Holowiecki, J. (2003) Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102, 814-819.
143. Beelen, D. W., Ottinger, H. D., Ferencik, S., Elmaagacli, A. H., Peceny, R., Trenschel, R., Grosse-Wilde, H. (2005) Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the longterm antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 105, 2594-2600.
144. Pende, D., Marcenaro, S., Falco, M., Martini, S., Bernardo, M. E., Montagna, D., Romeo, E., Cognet, C., Martinetti, M., Maccario, R., Mingari, M. C., Vivier, E., Moretta, L., Locatelli, F., Moretta, A. (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113, 3119-3129.
145. Cook, M. A., Milligan, D. W., Fegan, C. D., Darbyshire, P. J., Mahendra, P., Craddock, C. F., Moss, P. A., Briggs, D. C. (2004) The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103, 1521-1526.
146. Hsu, K. C., Keever-Taylor, C. A., Wilton, A., Pinto, C., Heller, G., Arkun, K., O'Reilly, R. J., Horowitz, M. M., Dupont, B. (2005) Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105, 4878-4884.
147. Verheyden, S., Schots, R., Duquet, W., Demanet, C. (2005) A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 19, 1446-1451.
148. Ayello, J., van de Ven, C., Cairo, E., Hochberg, J., Baxi, L., Satwani, P., Cairo, M. S. (2009) Characterization of natural killer and natural killerlike T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Exp. Hematol. 37, 1216-1229.
149. Velardi, A., Ruggeri, L., Mancusi, A., Aversa, F., Christiansen, F. T. (2009) Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia. Curr. Opin. Immunol. 21, 525-530.
150. Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., Orchard, P. J., Blazar, B. R., Wagner, J. E., Slungaard, A., Weisdorf, D. J., Okazaki, I. J., McGlave, P. B. (2005) Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051-3057.
151. Gutman, J. A., Turtle, C. J., Manley, T. J., Heimfeld, S., Bernstein, I. D., Riddell, S. R., Delaney, C. (2010) Single-unit dominance after doubleunit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood 115, 757-765.
152. Marchant, A., Goldman, M. (2005) T cell-mediated immune responses in human newborns: ready to learn? Clin. Exp. Immunol. 141, 10-18.
153. Malhotra, I., Wamachi, A. N., Mungai, P. L., Mzungu, E., Koech, D., Muchiri, E., Moormann, A. M., King, C. L. (2008) Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33). J. Immunol. 180, 3383-3390.
154. Hermann, E., Truyens, C., Alonso-Vega, C., Even, J., Rodriguez, P., Berthe, A., Gonzalez-Merino, E., Torrico, F., Carlier, Y. (2002) Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100, 2153-2158.